HT
ALT icon

Headlands Technologies’s Altimmune ALT Stock Holding History

Headlands Technologies’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,557
Closed -$71.8K – 624
2025
Q2 		$71.8K Buy
+18,557
New +$100K 0.01% 700
2025
Q1 		– Sell
-14,054
Closed -$101K – 1119
2024
Q4 		$101K Buy
+14,054
New +$107K 0.01% 661

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Headlands Technologies's ALT Position: Q3 2025 in Review

Headlands Technologies sold out of Altimmune (ALT) in Q3 2025, closing a stake of 18,557 shares — an estimated $71.8K sold.

Headlands Technologies first reported a position in ALT in Q4 2024 and held it in 2 quarters. The position peaked at $101K in Q4 2024. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Headlands Technologies reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 18,557 Altimmune shares in Q3 2025, an estimated $71.8K.
  • Headlands Technologies first reported a position in Altimmune in Q4 2024 and held it in 2 quarters.
  • Headlands Technologies's Altimmune position peaked at $101K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.